Elizabeth Abigail Gomez, | |
1301 Barbara Jordan Blvd Ste 302, Austin, TX 78723-3078 | |
(512) 472-6134 | |
(512) 472-4601 |
Full Name | Elizabeth Abigail Gomez |
---|---|
Gender | Female |
Speciality | Physician Assistant |
Location | 1301 Barbara Jordan Blvd Ste 302, Austin, Texas |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528774171 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | PA17365 (Texas) | Secondary |
363A00000X | Physician Assistant | PA17365 (Texas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Elizabeth Abigail Gomez, 1301 Barbara Jordan Blvd Ste 302, Austin, TX 78723-3078 Ph: (512) 472-6134 | Elizabeth Abigail Gomez, 1301 Barbara Jordan Blvd Ste 302, Austin, TX 78723-3078 Ph: (512) 472-6134 |
News Archive
Homewood Health Inc. has launched a bold new advertising campaign in the southern Alberta market to create awareness of its first new mental health and addiction treatment clinic, The Homewood Clinic, located in southwest Calgary.
Simcere Pharmaceutical Group, a leading manufacturer and supplier of branded generic pharmaceuticals and manufacturer of the patented anti-cancer biotech product Endostar (also known as Endu) in China, announced today the successful completion of Endostar Phase IV clinical study at a conference in Beijing dedicated to this study.
Edgemont Pharmaceuticals, LLC, a neuroscience focused company, today announced that the U.S. Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Fluoxetine Tablets 60 mg.
Vertex Pharmaceuticals Incorporated today announced the final results from its pivotal Phase 3 STRIVE study that evaluated VX-770, a medicine in development that targets the defective protein that causes cystic fibrosis (CF).
› Verified 8 days ago